Nektar Therapeutics (NKTR) Operating Leases (2019 - 2026)
Nektar Therapeutics' Operating Leases was $55.85 million in Q2 2026, down 24.7% from $74.15 million a year earlier and down 7.9% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Nektar Therapeutics came in at $65.26 million, down 21.1% from FY2024.
- Operating Leases has now declined for six consecutive years, with a five-year compound annual growth rate of -13.7% (FY2020 to FY2025).
- In earlier years, Operating Leases was $82.7 million in FY2024 (-16.1%), $98.52 million in FY2023 (-12.7%), $112.83 million in FY2022 (-10.3%) and $125.74 million in FY2021 (-7.8%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases in data going back to Q1 2019.
- Compared with a year earlier, Operating Leases has declined for 24 straight quarters, with an average decline of 19.3% over the last eight quarters.
- The year-over-year decline in Operating Leases has ranged between 7.4% (Q3 2021) and 24.7% (Q2 2026) over the last five years.
- Per Business Quant data, NKTR's Operating Leases in the three quarters before Q2 2026 was $60.63 million (Q1 2026), $65.26 million (Q4 2025) and $69.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Nektar Therapeutics | 2.00 Bn | 227.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.85 Mn |
| Mar 31, 2026 | 60.63 Mn |
| Dec 31, 2025 | 65.26 Mn |
| Sep 30, 2025 | 69.73 Mn |
| Jun 30, 2025 | 74.15 Mn |
| Mar 31, 2025 | 78.50 Mn |
| Dec 31, 2024 | 82.70 Mn |
| Sep 30, 2024 | 86.76 Mn |
| Jun 30, 2024 | 90.76 Mn |
| Mar 31, 2024 | 94.71 Mn |
| Dec 31, 2023 | 98.52 Mn |
| Sep 30, 2023 | 102.19 Mn |
| Jun 30, 2023 | 105.82 Mn |
| Mar 31, 2023 | 109.39 Mn |
| Dec 31, 2022 | 112.83 Mn |
| Sep 30, 2022 | 116.15 Mn |
| Jun 30, 2022 | 119.42 Mn |
| Mar 31, 2022 | 122.64 Mn |
| Dec 31, 2021 | 125.74 Mn |
| Sep 30, 2021 | 128.72 Mn |
API Access
Nektar Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();